By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
OviTex Reinforced Tissue Matrix (OviTex)51.22M63.81%
OviTex Reinforced Tissue Matrix (OviTex) Plastic and Reconstructive Surgery (PRS)27.31M34.02%
Other1.75M2.17%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States68.18M84.93%
Outside of the U.S.12.1M15.07%